ACTA ENDOCRINOLOGICA (BUC)

The International Journal of Romanian Society of Endocrinology / Registered in 1938

in Web of Science Master Journal List

Acta Endocrinologica(Bucharest) is live in PubMed Central

Journal Impact Factor - click here.

Year Volume Issue First page
10.4183/aeb.
Author
Title
Abstract/Title
From through

  • Images in Endocrinology

    Panaitescu AM, Vayna AM

    A Case of Uncontrolled Maternal Diabetes Mellitus Associated with Fetal Sacral Agenesis

    Acta Endo (Buc) 2018 14(1): 132-132 doi: 10.4183/aeb.2018.132

  • Actualities in medicine

    Vintila M

    Diabetology in Clinical Research

    Acta Endo (Buc) 2015 11(1): 132-133 doi: 10.4183/aeb.2015.132

  • Guidelines

    Chirita Emandi A, Puiu M, Gafencu M, Pienar C

    Growth References for School Aged Children in Western Romania

    Acta Endo (Buc) 2012 8(1): 133-152 doi: 10.4183/aeb.2012.133

    Abstract
    Aims. To provide growth references for school-aged children in western Romania, to compare them with other national and\r\ninternational growth charts and evaluate the prevalence of overweight and obesity.\r\nMethods. A total of 3731 children, aged 7-19 years, from Timis county, were examined by medical students, between\r\nFebruary 2010-June 2011. Growth references for height, weight, and body mass index (BMI) were constructed with LMS method and LMSChartMaker software. The Romanian 3rd, 50th and 95th percentile for height and BMI were compared with national and international growth references. The prevalence of overweight and obesity was determined with IOTF definition.\r\nResults. Crude and smoothed percentiles for weight, height and BMI were shown for this population. The comparison\r\nprovided data regarding the variation of growth models in different populations. Our results demonstrated a high prevalence of overweight (18.2%) and obesity (7.2%) in our\r\npopulation, higher in boys versus girls.\r\nConclusions. Our study constructed growth references for a Romanian population. The comparison with other growth references reflected the regional differences in growth\r\npatterns between populations.
  • General Endocrinology

    Koshinatam K, Oshida Y, Kubota M, Sato Y

    Exposure to nitric oxide does not induce insulin resistance of glucose uptake in isolated rat epitrochlearis muscle

    Acta Endo (Buc) 2008 4(2): 133-142 doi: 10.4183/aeb.2008.133

    Abstract
    Accumulating evidence indicates that induction of inducible nitric oxide (NO) synthase and the subsequent NO production may be involved in the pathogenesis of insulin resistance. However the role of NO on insulin action of glucose uptake in skeletal muscle is not clearly understood. We hypothesized that NO does not impair insulin action of glucose uptake in skeletal muscle. To test this hypothesis, isolated rat epitrochlearis muscles were incubated in the presence or absence of sodium nitroprusside (SNP), a NO donor, with or without insulin, followed by measurement of glucose uptake. A low concentration of SNP (0.1 mM) did not stimulate glucose uptake, whereas a high concentration of SNP (10 mM) caused a large increase in glucose uptake in the absence of insulin (basal: 1.08?0.13; 0.1mM SNP: 1.32?0.11; 10 mM SNP:3.85?0.32 μmol/ml/20 min) When muscles were incubated in the presence of 0.1 mM SNP with insulin, the glucose uptake was not significantly different than that induced by insulin alone (insulin: 3.54?0.34; insulin+0.1mM SNP: 4.42?0.37 μmol/ml/20 min). In the presence of 10 mM SNP with insulin, the combined effect on glucose uptake was greater than that induced by insulin alone (insulin+10mM SNP: 6.32 ? 0.31 μmol/ml/20 min). The calculation of net increase of insulinstimulated glucose uptake (SNP+insulin minus SNP alone) clearly demonstrated that insulin action of glucose uptake was not impaired by SNP. Furthermore, wortmannin did not inhibit SNPstimulated glucose uptake and NG-monomethyl-L-arginine, a NO synthase (NOS) inhibitor, also did not block insulin-stimulated glucose uptake, indicating no interaction between NO signaling and insulin signaling in glucose uptake mechanisms. These results strongly suggest that NO does not induce insulin resistance of glucose uptake in isolated rat epitrochlearis muscle.
  • Notes & Comments

    Yilmaz O, Mevsim V, Kuruoglu E

    Development of Clinical Risk Assessment Tool for Osteoporosis (Osteoriskapp) Using a Syndromic Approach

    Acta Endo (Buc) 2018 14(1): 133-141 doi: 10.4183/aeb.2018.133

    Abstract
    Context. DEXA is recommended for osteoporosis screening. However, the rate of screening with DEXA is very low. Therefore, methods that can be used more easily and cost effectively are needed. Objective. The objective of this study is to develop a clinical risk assessment tool of osteoporosis (OSTEORISKAPP) by using syndromic approach. Design. A methodological study was performed. Subjects and Methods. Three hundred and fiftysix participants who are above 50 years old are participants of study and take history and physical examination. Positive likelihood ratio (LR), pre and post test probability, is calculated. A logistic regression analysis and a ROC analysis are made with the model constructed by those criteria. Results. Eighteen different clinical risk indices are diagnosed. According to LR, 4 of these criteria are minimally effective, 11 of them are weakly effective and 3 of them are medium effective criteria According to results of logistic regression analysis, back pain, waist pain, and usage of cortisone for more than 3 months, vertebra tenderness in physical examination, having dorsal kyphosis and being obese are turned out to be statistically significant in 89.9% confidence interval. AUC is found to be 0.948 and diagnostic test is found to have perfect distinction ability. Conclusion. Syndromic diagnostic criteria that will be used for osteoporosis screening of population and that is cost effective, no need to refer, practical, reliable and has tried to be developed.
  • Notes & Comments

    Malutan A, Costin N., Duncea I., Georgescu Pepene C.E., Mihu D., Rada MP

    Interleukin-8 and vasomotor symptoms in natural and surgically induced menopause

    Acta Endo (Buc) 2013 9(1): 133-144 doi: 10.4183/aeb.2013.133

    Abstract
    Objectives. The aim of this study was to evaluate serum levels of interleukin (IL)-8 in pre- and postmenopausal women and in patients with surgically-induced menopause, and the relationship between IL-8 and vasomotor symptoms. Material and Method. 175 women were enrolled and were divided into 5 groups (I – Fertile women; II – Pre- and perimenopausal women; III – Postmenopausal women; IV – Surgically-induced menopause; V – Chronic inflammation). Multiplex cytokine kits were used to evaluate serum levels of interleukin-8. We determined the serum levels of the follicle stimulating hormone, of the luteinizing hormone, 17β-estradiol, progesterone, dehydroepiandrosterone and dehydroepiandrosterone sulfate using sandwich ELISA. The severity of the vasomotor symptoms was evaluated according to FDA guidelines. Results. Serum concentration of IL-8 in women with natural menopause (233.0±226.5 pg/ml; p<0.001) and in women with surgically-induced menopause (148.0±162.0 pg/ml; p=0.045) is significantly higher than in women of reproductive age (84.88±82.32 pg/ml). Serum levels of IL-8 in premenopausal women, postmenopausal women, and in women with surgically-induced menopause, respectively, with severe and moderate hot flashes, on one hand (174.8±90.94 pg/ml, 369.3±194.2 pg/ml, respectively 274.1±146.3 pg/ml), is significantly higher than in women without vasomotor symptoms or with mild hot flashes, on the other hand (19.97±22.15 pg/ml, 28.66±35.72 pg/ml, respectively 28.94±37.68 pg/ml; p<0.001). Serum levels of IL-8 are significantly higher in women of reproductive age with chronic inflammatory pathology (152.3±121.0 pg/ml) than in women without such pathology (84.88±82.32 pg/ml; p=0.02). Conclusions. IL-8 is significantly higher in postmenopausal women with vasomotor symptoms than in women without vasomotor symptoms. In the postmenopausal group, the serum levels of IL-8 are similar to those in women with chronic inflammatory pathology. IL-8 could be a key factor in occurrence of hot flashes in menopause and could be associated with peripheral vasodilatation in these women.
  • Notes & Comments

    Pricop C, Radavoi GD, Puia D, Vechiu C, Jinga V

    Obesity: a Delicate Issue Choosing the Eswl Treatment for Patients with Kidney and Ureteral Stones?

    Acta Endo (Buc) 2019 15(1): 133-138 doi: 10.4183/aeb.2019.133

    Abstract
    Context. Urolithiasis and obesity are now public health problems with an increased incidence worldwide. Management of urolithiasis in patients with morbid obesity is usually associated with higher morbidity and mortality compared to non-obese patients. ESWL is a nonsurgical procedure for the treatment of lithiasis. In obese patients the ESWL efficacy is influenced by the skin-to-stone distance or poorer detection of the calculus because of the fatty tissue. Objective. To highlight the overweight or obese lithiasic patient profile that could be best treated by ESWL. Subjects and Methods. We evaluated ESWL results in 1393 patients with kidney or ureteral stones between 5 and 20 mm. They were divided into 4 groups according to the BMI: Group A-overweight (BMI=25-30 kg/ m2); Group B-grade I obesity (BMI=30-35 kg/m2); Group C-grade II obesity (BMI=35-40 kg/m2) and a control group of normal weight (BMI=18-25 kg/m2). Results. Patients with a higher BMI required a greater number of ESWL sessions. A statistically significant greater number of patients with a waist circumference of >102 cm required more than 2 SWL sessions (p=0.007). Location of the stones in the pelvic ureter had the highest rate of success for obese patients (p=0.00001). The ESWL success rate in overweight and obese patients can be negatively influenced by BMI, abdominal circumference over 102 cm, and hardness of calculi reflected in the radiopacity on KUB. Conclusions. In patients with grade II obesity, pyelocaliceal calculus and increased hardness, other urological alternatives to lithiasis should be considered from the beginning.
  • Perspectives

    Mori K, Emoto M, Numaguchi R, Numaguchi R, Yamazaki Y, Urata H, Motoyama K, Morioka T, Shoji T, Inaba M

    Potential Advantage of Repaglinide Monotherapy in Glycemic Control in Patients with Type 2 Diabetes and Severe Renal Impairment

    Acta Endo (Buc) 2017 13(2): 133-137 doi: 10.4183/aeb.2017.133

    Abstract
    Context. Oral anti-diabetic drugs (OADs) are leading option for treatment of type 2 diabetes (T2D). However, availability of OADs are limited in the presence of renal impairment (RI). Objective. In this study, we examined the efficacy of repaglinide, which is mainly metabolized and excreted via non-renal route, in patients with T2D and severe RI that consists mainly of chronic kidney disease (CKD) stage 4. Design, Subjects and Methods. This was an open label, single arm, interventional study by repaglinide monotherapy. The primary efficacy end point was HbA1c change from baseline to week 12. Results. Repaglinide treatment significantly reduced HbA1c levels from 7.7 ± 0.7% to 6.1 ± 0.3% (p<0.001) in 9 patients with severe RI (mean estimated glomerular filtration rate was 26.4 ± 7.5 mL/min/1.73m2). Focusing on 4 patients who received DPP-4 inhibitor monotherapy at enrolment, switching to repaglinide also significantly improved HbA1c levels. No hypoglycemic symptoms or severe hypoglycemia was reported in patients who completed the period of 12 weeks. Conclusions. We demonstrated the efficacy of repaglinide in patients with T2D and severe RI. In case that DPP-4 inhibitors are not enough to achieve targeted range of glycemic control, repaglinide is another good candidate.
  • Notes & Comments

    Sarafoleanu C, Badea C, Lupoi D

    Bilateral Carotid Body Paragangliomas - Literature Review and Comments in a Patient with no Signs of Men Syndrome

    Acta Endo (Buc) 2023 19(1): 133-141 doi: 10.4183/aeb.2023.133

    Abstract
    Paragangliomas are rare neuroendocrine slowgrowing tumors, often asymptomatic, that originate from embryonic neural crest cell. In the head and neck area, the most common location is the carotid body, followed, with decreasing frequency, in jugular, tympanic and vagal sites. Bilateral carotid body tumors are extremely rare. Aim. To present the most important features of carotid body paragangliomas, illustrating the clinical characteristics, associated with a thorough analysis of the diagnostic imaging elements, but also the current therapeutic strategies, with respective anatomical, surgical considerations and potential complications that can occur. Surgical resection is the main line of treatment. The complex anatomy of the cervical region and the close relationships of carotid body paragangliomas with carotid vessels and cranial nerves, as well as its intense vascularization makes the surgical intervention a real challenge even for an experienced surgeon. Discussion. Starts from a bilateral carotid paraganglioma in a 35-year-old male, with painless lateral neck swelling, accidentally discovered by his barber about two years ago. Diagnosis was suspected on the basis of history, clinical and radiological findings. “Wait and scan” strategy plus endocrinologic assessment for MEN syndromes were considered the optimal therapeutic approach in this case.
  • Actualities in medicine

    Bacinschi XE, Anghel RM

    Advances in Radiotherapy of Adrenal Gland Lesions

    Acta Endo (Buc) 2022 18(1): 134-137 doi: 10.4183/aeb.2022.134

    Abstract
    Primary adrenal tumors include a broad variety of lesions, from nonfunctioning incidentalomas to secreting adrenocortical adenomas including Aldosteronism, Cushing or androgen secreting lesions. Primary tumors can occur either in the cortex or the medulla of the adrenal glands, having different histopathological features and also different clinical appearances and treatment approaches. In addition, the adrenal glands can become distant metastatic sites of numerous primary malignancies. The first line of treatment in a broad variety of cases is surgery. After pathology results, in selected cases, apart the oncologic approach, radiotherapy could be an important therapeutic tool. In this paper we will discuss the role of radiotherapy in the treatment of adrenal gland lesions.